PPC Stock Analysis: Pilgrims Pride | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 6.557m USD | 12M Return: -32.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.1M
EPS Trend: 82.5%
Qual. Beats: -1
Rev. Trend: 96.9%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
Pilgrims Pride Corporation produces, processes, markets, and distributes fresh, frozen, and value-added chicken and pork products, operating across the United States, Europe, and Mexico. The companys product range spans refrigerated whole and cut-up chicken, marinated and non-marinated chicken parts, primary pork cuts, fully cooked and ready-to-cook items, processed sausages, bacon, smoked meats, and prepared foods such as nuggets, patties, and sandwich meats. Beyond traditional animal protein, Pilgrims also offers plant-based proteins, ready-to-eat meals, multi-protein frozen foods, vegetarian items, and desserts. Like most large poultry processors, the business is vertically integrated, controlling stages from breeding and feed milling through processing and distribution, which ties margins to volatile input costs such as corn and soybean meal.
The company sells its products under a wide portfolio of brands, including Pilgrims, Just BARE, Goldn Pump, Gold Kist, County Pride, Pierce Chicken, Pilgrims Mexico, To-Ricos, Del Dia, Moy Park, Mattesons, Richmond, Fridge Raiders, and Denny. Its customer base spans chain restaurants, food processors, broad-line distributors, grocery store chains, wholesale clubs, and other retail and institutional outlets. Founded in 1946 and headquartered in Greeley, Colorado, Pilgrims Pride operates as a subsidiary of JBS N.V., a Brazilian parent that is one of the worlds largest meat processors, giving PPC access to global production, distribution, and procurement capabilities that few independent peers can match.
- Feed grain costs pressure chicken processing margins
- JBS parent capital allocation drives buybacks and dividends
- Avian flu outbreaks disrupt US poultry production and pricing
| Net Income: 887.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -7.31 > 1.0 |
| NWC/Revenue: 7.04% < 20% (prev 7.66%; Δ -0.62% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.39b > Net Income 887.7m |
| Net Debt (3.06b) to EBITDA (1.87b): 1.63 < 3 |
| Current Ratio: 1.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (238.6m) vs 12m ago 0.12% < -2% |
| Gross Margin: 11.57% > 18% (prev 13.81%; Δ -2.24% > 0.5%) |
| Asset Turnover: 175.4% > 50% (prev 164.0%; Δ 11.45% > 0%) |
| Interest Coverage Ratio: 8.90 > 6 (EBIT TTM 1.40b / Interest Expense TTM 157.5m) |
| A: 0.13 (Total Current Assets 4.03b - Total Current Liabilities 2.72b) / Total Assets 10.2b |
| B: 0.23 (Retained Earnings 2.35b / Total Assets 10.2b) |
| C: 0.13 (EBIT TTM 1.40b / Avg Total Assets 10.6b) |
| D: 0.58 (Book Value of Equity 3.72b / Total Liabilities 6.47b) |
| Altman-Z'' = 3.08 = A |
| DSRI: 0.98 (Receivables 1.18b/1.17b, Revenue 18.6b/18.0b) |
| GMI: 1.19 (GM 13.81% / 11.57%) |
| AQI: 1.12 (AQ_t 0.22 / AQ_t-1 0.20) |
| SGI: 1.03 (Revenue 18.6b / 18.0b) |
| TATA: -0.05 (NI 887.7m - CFO 1.39b) / TA 10.2b) |
| Beneish M = -2.78 (Cap -4..+1) = A |
As of June 30, 2026, the stock is trading at USD 28.95 with a total of 1,656,381 shares traded. Over the past week, the price has changed by +4.72%, over one month by +1.42%, over three months by -20.81% and over the past year by -32.83%.
Current recommended Stop Loss: 26.00 (which is 10.2% or 2.7 ATR below the current price).
Pilgrims Pride has received a consensus analysts rating of 3.11. Therefore, it is recommended to hold PPC.
- StrongBuy: 1
- Buy: 0
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 39.3 | 35.6% |
P/E Trailing = 7.3887
P/E Forward = 7.4516
P/S = 0.3532
P/B = 1.762
P/EG = 0.4882
Revenue TTM = 18.6b USD
EBIT TTM = 1.40b USD
EBITDA TTM = 1.87b USD
Long Term Debt = 3.10b USD (from longTermDebt, last quarter)
Short Term Debt = 60.0m USD (from shortTermDebt, last quarter)
Debt = 3.60b USD (from shortLongTermDebtTotal, last quarter) + Leases 252.1m
Net Debt = 3.06b USD (calculated: Debt 3.60b - CCE 542.4m)
Enterprise Value = 9.62b USD (6.56b + Debt 3.60b - CCE 542.4m)
Interest Coverage Ratio = 8.90 (Ebit TTM 1.40b / Interest Expense TTM 157.5m)
EV/FCF = 17.87x (Enterprise Value 9.62b / FCF TTM 538.0m)
FCF Yield = 5.60% (FCF TTM 538.0m / Enterprise Value 9.62b)
FCF Margin = 2.90% (FCF TTM 538.0m / Revenue TTM 18.6b)
Net Margin = 4.78% (Net Income TTM 887.7m / Revenue TTM 18.6b)
Gross Margin = 11.57% ((Revenue TTM 18.6b - Cost of Revenue TTM 16.4b) / Revenue TTM)
Gross Margin QoQ = 7.62% (prev 9.49%)
Tobins Q-Ratio = 0.94 (Enterprise Value 9.62b / Total Assets 10.2b)
Interest Expense / Debt = 4.37% (Interest Expense 157.5m / Debt 3.60b)
Taxrate = 28.55% (355.1m / 1.24b)
NOPAT = 1.00b (EBIT 1.40b * (1 - 28.55%))
Current Ratio = 1.48 (Total Current Assets 4.03b / Total Current Liabilities 2.72b)
Debt / Equity = 0.97 (Debt 3.60b / totalStockholderEquity, last quarter 3.72b)
Debt / EBITDA = 1.63 (Net Debt 3.06b / EBITDA 1.87b)
Debt / FCF = 5.68 (Net Debt 3.06b / FCF TTM 538.0m)
Total Stockholder Equity = 3.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.39% (Net Income 887.7m / Total Assets 10.2b)
RoE = 24.19% (Net Income TTM 887.7m / Total Stockholder Equity 3.67b)
RoCE = 20.71% (EBIT 1.40b / Capital Employed (Equity 3.67b + L.T.Debt 3.10b))
RoIC = 14.30% (NOPAT 1.00b / Invested Capital 7.00b)
WACC = 3.95% (E(6.56b)/V(10.2b) * Re(4.40%) + D(3.60b)/V(10.2b) * Rd(4.37%) * (1-Tc(0.29)))
Discount Rate = 4.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 94.39 | Cagr: 0.20%
[DCF] Terminal Value 73.10% ; FCFF base≈874.8m ; Y1≈767.1m ; Y5≈619.8m
[DCF] Fair Price = 28.96 (EV 9.95b - Net Debt 3.06b = Equity 6.89b / Shares 237.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 82.46 | EPS CAGR: 99.49% | SUE: -0.92 | # QB: -1
Revenue Correlation: 96.91 | Revenue CAGR: 3.25% | SUE: 0.95 | # QB: 2
EPS next Quarter (2026-09-30): EPS=1.11 | Chg30d=-12.62% | Revisions=-50% | Analysts=4
EPS current Year (2026-12-31): EPS=3.48 | Chg30d=-14.66% | Revisions=-60% | GrowthEPS=-32.8% | GrowthRev=+1.5%
EPS next Year (2027-12-31): EPS=3.78 | Chg30d=-6.81% | Revisions=-60% | GrowthEPS=+8.6% | GrowthRev=+1.5%
[Analyst] Revisions Ratio: -60%